WebHá 1 dia · Washington - Results of a phase 3a laboratory study suggest that a novel topical nitroglycerin (NTG) gel (Vascana, MediQuest Therapeutics) has exciting potential as a … WebRaynaud's phenomenon is a circulatory disorder, characterised by episodic attacks where arteries in the fingers and toes spasm, restricting blood flow and causing pain and marked colour changes of the skin. In this article Diagnosis is based on clinical symptoms and signs Raynaud’s can be primary or secondary
Raynaud
Web31 de mai. de 2007 · The purpose of this clinical study is to determine the response to two different dosage strengths of a topical nitroglycerin gel in patients with Raynaud's … WebCondition(s) targeted: Raynaud's Disease. Intervention: Nitroglycerin (Drug) Phase: Phase 2. Status: Completed. Sponsored by: MediQuest Therapeutics. Official(s) and/or principal … the manere sydney
Use of nitroglycerin ointment to treat primary and …
WebThe purpose of the study was to evaluate the hemodynamics of nitroglycerin ointment in Raynaud's phenomenon. 22 patients (15 women and 7 men aged 25-75 years) suffering … WebNitroglycerin is in a class of medications called vasodilators. It works by relaxing the blood vessels so that the heart does not need to work as hard and therefore does not need as much oxygen. How should this medicine be used? Transdermal nitroglycerin comes as a patch to apply to the skin. WebAbstract Citations & impact Similar Articles Treatment of Raynaud's diseases with nitroglycerine. the man episode